"LM_ID","COMMON_NAME","SYSTEMATIC_NAME","FORMULA","MASS","CATEGORY","MAIN_CLASS","SUB_CLASS","CLASS_LEVEL4","SYNONYMS","INCHI_KEY","INCHI","SMILES","KEGG_ID","HMDBID","CHEBI_ID","ABBREVIATION","PUBCHEM_COMPOUND_ID","LIPIDBANK_ID","SWISSLIPIDS_ID","CAYMAN_ID","ALT_CATEGORIES","ALT_MAIN_CLASSES","ALT_SUB_CLASSES","ALT_CLASS_LEVEL4S","TAXONOMY","CITATION"
"LMSP0505AP02","I antigen(d18:1/18:0)","Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)","C90H160N4O43","1985.045643","Sphingolipids [SP]","Neutral glycosphingolipids [SP05]","Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]","-","-","QQHMZZGJSFUXQW-RFGXDRQWSA-N","InChI=1S/C90H160N4O43/c1-6-8-10-12-14-16-18-20-21-23-25-27-29-31-33-35-58(106)94-48(49(105)34-32-30-28-26-24-22-19-17-15-13-11-9-7-2)43-122-86-74(119)71(116)80(56(42-101)130-86)135-89-75(120)81(64(109)52(38-97)126-89)136-84-61(93-47(5)104)68(113)79(55(41-100)129-84)134-90-76(121)82(137-85-60(92-46(4)103)67(112)78(54(40-99)128-85)133-88-73(118)70(115)63(108)51(37-96)125-88)65(110)57(131-90)44-123-83-59(91-45(3)102)66(111)77(53(39-98)127-83)132-87-72(117)69(114)62(107)50(36-95)124-87/h32,34,48-57,59-90,95-101,105,107-121H,6-31,33,35-44H2,1-5H3,(H,91,102)(H,92,103)(H,93,104)(H,94,106)/b34-32+/t48-,49+,50+,51+,52+,53+,54+,55+,56+,57+,59+,60+,61+,62-,63-,64-,65-,66+,67+,68+,69-,70-,71+,72+,73+,74+,75+,76+,77+,78+,79+,80+,81-,82-,83+,84-,85-,86+,87-,88-,89-,90-/m0/s1","[C@](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO[C@@H]5O[C@H](CO)[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5NC(=O)C)[C@H](O)[C@H](O[C@@H]5O[C@H](CO)[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5NC(=O)C)[C@H]4O)[C@H](O)[C@H]3NC(=O)C)[C@H]2O)[C@H](O)[C@H]1O)([H])(NC(CCCCCCCCCCCCCCCCC)=O)[C@]([H])(O)/C=C/CCCCCCCCCCCCC","-","-","-","Hex(5)-HexNAc(3)-Cer 36:1;O2","178332020","-","-","-","-","-","-","-","-","-"